“Surviving Pneumonectomy: Identifying key determinants and outcomes.”

Author:

Feyissa Mekonnen1,Gullilat Dereje2,kassa seyoum2,Bezabih Abebe2

Affiliation:

1. Addis Ababa University. Addis Ababa

2. General and Cardiothoracic Surgeon, Tikur Anbessa Hospital, Addis Ababa University. Addis Ababa

Abstract

Abstract Background: Pneumonectomy is a surgical procedure that involves the complete removal of a lung and was first performed in 1933 by Evarts A. Graham for lung carcinoma. Despite its efficacy in treating lung diseases, Pneumonectomy is associated with high morbidity and mortality rates compared to other lung resection procedures. Methods: This retrospective case-control study included 180 patients who underwent Pneumonectomy or Other lung resection at TASH between January 2017 and December 2022. Data were collected using a checklist by trained data collectors and analyzed using SPSS V.25. Univariate, bivariate, and multivariate analyses were conducted to identify determinants of Pneumonectomy. The Pearson's chi-square test, COR, and AOR were calculated for categorical variables, where appropriate. Binary logistic regression models were computed to identify determinants of Pneumonectomy, and odds ratios with 95% confidence intervals were calculated. Results: The majority of patients who underwent Pneumonectomy were in the 20-30 age range (48.2%), with a male to female ratio of 1.6:1. Emergency admission (AOR, 3.43; 95%CI: 1.28, 8.67), TB treatment history (AOR, 40.3; 95%CI: 3.01, 540.2), blood loss (AOR, 9.07; 95%CI: 1.04, 79.13), ICU stay (AOR, 0.02; 95%CI: 0.001, 0.17), and post-operative complications (AOR, 37.9; 95%CI: 1.82, 792) were identified as significant determinants of Pneumonectomy. Conclusion: This study identified several determinants of Pneumonectomy, including emergency admission, TB treatment history, blood loss, ICU stay, and post-operative complications. The study recommends a focus on TB prevention strategies and proper patient evaluation before treatment at all health facility levels to improve patient outcomes and reduce the incidence of postoperative complications.

Publisher

Research Square Platform LLC

Reference36 articles.

1. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington JA;Chest,2013

2. The treatment of carcinoma of the lung;Graham EA;Ann Surg,1933

3. L'exérèse pulmonaire totale par voie extrapleurale dans le traitement de la tuberculose pleurale;Sarot JR;Rev Tuberc,1949

4. Predictors of perioperative morbidity and mortality after pneumonectomy using the National Surgical Quality Improvement Program database;Raman V;Ann Thorac Surg,2016

5. Risk factors for bronchopleural fistula after extrapleural pneumonectomy for malignant pleural mesothelioma;Watanabe A;Eur J Cardiothorac Surg,2012

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3